1-4 of 4
Kyungho Kim, PhD
Close
Sort by
Journal Articles

Specific Inhibition of AKT with ARQ 092, an Orally-Available Selective AKT Inhibitor, Attenuates Acute Vaso-Occlusive Events in Sickle Cell Disease

Jing Li, PhD, Kyungho Kim, PhD, Alan Tseng, Andrew Barazia, PhD, Seock-Won Youn, Giovanni Abbadessa, MD, Yi Yu, PhD, Brian Schwartz, MD, Robert K Andrews, PhD, Victor R. Gordeuk, MD, Jaehyung Cho, PhD
Journal: Blood
Blood (2016) 128 (22): 160.
https://doi.org/10.1182/blood.V128.22.160.160
Published: 2016
Journal Articles

Platelet Surface PDI Controls the Ligand-Binding Function of Glycoprotein Ibalpha and Platelet-Neutrophil Interactions Under Thromboinflammatory Conditions

Kyungho Kim, PhD, Jing Li, PhD, Robert K Andrews, PhD, Joyce Chiu, PhD, Philip Hogg, PhD, Jaehyung Cho, PhD
Journal: Blood
Blood (2015) 126 (23): 235.
https://doi.org/10.1182/blood.V126.23.235.235
Published: 2015
Journal Articles

Co-Administration of Hydroxyurea and a Specific AKT2 Inhibitor Has Beneficial Effects on Acute Vaso-Occlusive Events and Survival in Sickle Cell Disease Mice

Jing Li, PhD, Andrew Barazia, Kyungho Kim, PhD, Jaehyung Cho, PhD
Journal: Blood
Blood (2015) 126 (23): 3383.
https://doi.org/10.1182/blood.V126.23.3383.3383
Published: 2015
Journal Articles

Neutrophil DREAM Is a Novel Regulator for Beta2 Integrin Function through NF-Kappab Signaling and Modulates Neutrophil Recruitment during Vascular Inflammation

Andrew Barazia, Jing Li, PhD, Kyungho Kim, PhD, Chinnaswamy Tiruppathi, PhD, Jaehyung Cho, PhD
Journal: Blood
Blood (2015) 126 (23): 888.
https://doi.org/10.1182/blood.V126.23.888.888
Published: 2015